DeepVerge has announced its proposed Q1 2022 launch of compact Microtox® PD surveillance units. This upgraded system significantly expands surveillance capabilities into smaller communities and/or facilities/locations where larger groups of
DeepVerge has announced its proposed Q1 2022 launch of compact Microtox® PD surveillance units. This upgraded system significantly expands surveillance capabilities into smaller communities and/or facilities/locations where larger groups of
Launch of compact Microtox® PD[i] surveillance units in Q1 2022
B2C and B2B offerings unveiled
In a potential landmark announcement, the Irish Government has today become the first to fully publicly endorse DeepVerge’s COVID-19 Microtox® PD technology.
Government of Ireland supports DeepVerge Centre of Excellence with €750k grant in a €1.8m project to accelerate mass production of a range of Microtox®PD instruments
DeepVerge has today announced a significant further step toward it becoming a key supplier to a national long-term COVID early-warning solution.
Skin Trust Club partners with Media.Monks to accelerate global expansion of hyper-personalised skincare brand launch
The planet is in trouble. Humanity’s health is in trouble. One of the main ways the environment is telling us this is in the information we can glean from wastewater
DeepVerge has announced its unaudited interim results for the six months ended 30 June 2021. Once again delivering on best financial expectations, H1 2021 revenues expanded by 231% to £3.319m
DeepVerge and Ion Exchange announce India Centre of Excellence for Modern Water All Membrane Brine Concentration (“AMBC”)
DeepVerge collaborate with Microsaic Systems plc to launch a range of miniature mass spectrometers with triple quadrupole limits of detection for organic chemical analysis in water and soil
DeepVerge’s AGM of 26 July 2021 provided its Board with an ideal platform to highlight both the Group’s transformational past year and the exceptional opportunities it now has to deliver